Active Opportunities by Industry

Pharmaceuticals Active Opportunities

2 Active Opportunities

Current international procurement relevant to U.S. Pharmaceuticals exporters. Listings change as international demand changes.

Explore the Pharmaceuticals export knowledge and resources →

Active
Goods
Pharmaceuticals

Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement according to § 130a Paragraph 8 SGB V for biosimilar active ingredients

§ 130a Paragraph 8 SGB V enables health insurance funds (KK) and pharmaceutical companies to conclude framework discount agreements for medicinal products to be dispensed at the expense of statutory health insurance funds. The the contracting authority acts for its shareholder an

Country
Germany
Deadline
Deadline August 10, 2027
View Active Opportunity →
Active
Goods
Pharmaceuticals

Germany – Pharmaceutical products – Conclusion of non-exclusive drug rebate agreements pursuant to Section 130a (8) SGB V as part of an open-house model for the active ingredient Epinephrine (WHO ATC code: C01CA24) in the dosage form of pre-filled syringe/pen

The subject of this publication is the conclusion of non-exclusive rebate agreements pursuant to Section 130a (8) SGB V for drugs containing the active ingredient Epinephrine (WHO ATC code: C01CA24) in the dosage form of pre-filled syringe/pre-filled pen - exclusive 500 microgram

Country
Germany
Deadline
Deadline September 30, 2027
View Active Opportunity →